27-Hydroxycholesterol Increases Myc Protein Stability Via Suppressing PP2A, SCP1 and FBW7 Transcription in MCF-7 Breast Cancer Cells
Overview
Affiliations
27-hydroxycholesterol (27-HC), the most abundant metabolite of cholesterol, is a risk factor for breast cancer. It can increase the proliferation of breast cancer cells and promote the metastasis of breast tumours in mouse models. Myc is a critical oncoprotein overexpressed in breast cancer. However, whether 27-HC affects Myc expression has not been reported. In the current study, we aimed to investigate the effects of 27-HC on Myc and the underlying mechanisms in MCF-7 breast cancer cells. Our data demonstrated that 27-HC activated Myc via increasing its protein stability. Three key negative modulators of Myc protein stability, PP2A, SCP1 and FBW7, were suppressed by 27-HC at the transcriptional level. We performed a data-mining analysis of the chromatin immunoprecipitation with next-generation DNA sequencing (ChIP-Seq) data in the ChIPBase, and discovered that a number of putative transcription factors (TFs), including Myc itself, were involved in the transcriptional regulation of PP2A, SCP1 and FBW7. Our results provide a novel mechanistic insight into the activation of Myc by 27-HC via transcriptional repression of PP2A, SCP1 and FBW7 to increase Myc protein stability in breast cancer cells.
FBXW7 in breast cancer: mechanism of action and therapeutic potential.
Chen S, Leng P, Guo J, Zhou H J Exp Clin Cancer Res. 2023; 42(1):226.
PMID: 37658431 PMC: 10474666. DOI: 10.1186/s13046-023-02767-1.
Zhao C, Liu J, Xu Y, Guo J, Wang L, Chen L Iran J Basic Med Sci. 2022; 25(10):1243-1250.
PMID: 36311195 PMC: 9588319. DOI: 10.22038/IJBMS.2022.65886.14492.
Takada I, Miyazaki T, Goto Y, Kanzawa H, Matsubara T, Namikawa-Kanai H Am J Cancer Res. 2022; 12(9):4241-4253.
PMID: 36225627 PMC: 9548011.
Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor.
Gu J, Zhu N, Li H, Zhao T, Zhang C, Liao D Cell Oncol (Dordr). 2022; 45(5):709-728.
PMID: 35864437 DOI: 10.1007/s13402-022-00694-5.
Yi X, Lou L, Wang J, Xiong J, Zhou S Cancer Chemother Pharmacol. 2021; 87(5):647-656.
PMID: 33544209 DOI: 10.1007/s00280-021-04238-w.